Pamela Kearns
- Oncology top 5%
- Molecular Biology top 10%
- Hematology top 2%
- Public Health, Environmental and Occupational Health top 5%
- Pediatrics, Perinatology and Child Health top 5%
- Co-authors
- Charlotte V. CoxAllison BlairRoger S. EvelyAndrew D.J. PearsonTracey PerryVictoria WestonGilles VassalGuy Pratt
- Topics
- Acute Lymphoblastic Leukemia research (45 papers)Childhood Cancer Survivors' Quality of Life (35 papers)Chronic Lymphocytic Leukemia Research (17 papers)
- Cited by
- HematologyOncologyGenetics
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- United KingdomNetherlandsFrance
In The Last Decade
Pamela Kearns
110 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 119
- Oncology 837
- Molecular Biology 830
- Hematology 487
- Public Health, Environmental and Occupational Health 470
- Pediatrics, Perinatology and Child Health 382
Countries citing papers authored by Pamela Kearns
This map shows the geographic impact of Pamela Kearns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Kearns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Kearns more than expected).
Fields of papers citing papers by Pamela Kearns
This network shows the impact of papers produced by Pamela Kearns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Kearns. The network helps show where Pamela Kearns may publish in the future.
Co-authorship network of co-authors of Pamela Kearns
This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Kearns. A scholar is included among the top collaborators of Pamela Kearns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Kearns. Pamela Kearns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 4 | |
| 6 | 4 | |
| 7 | 7 | |
| 8 | 9 | |
| 9 | 3 | |
| 10 | 90 | |
| 11 | 24 | |
| 12 | 23 | |
| 13 | 10 | |
| 14 | 5 | |
| 15 | 66 | |
| 16 | 12 | |
| 17 | The plasma and intracellular pharmacokinetics of clofarabine in pediatric leukemia patients | 2 |
| 18 | Investigation of urotensin-II converting enzyme activity in human cells and blood | 1 |
| 19 | 2 | |
| 20 | 21 |
About Pamela Kearns
Pamela Kearns is a scholar working on Genetics, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health, having authored 116 papers that have together received 2.3k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (45 papers), Childhood Cancer Survivors' Quality of Life (35 papers) and Chronic Lymphocytic Leukemia Research (17 papers). The work is most often cited by research in Hematology (487 citations), Oncology (837 citations) and Genetics (318 citations). Pamela Kearns has collaborated with scholars based in United Kingdom, Netherlands and France. Frequent co-authors include Charlotte V. Cox, Allison Blair, Roger S. Evely, Andrew D.J. Pearson, Tracey Perry, Victoria Weston, Gilles Vassal, Guy Pratt, Andrew G. Hall and Tatjana Stanković. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.